Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms

被引:599
作者
Ramage, G
vande Walle, K
Wickes, BL
López-Ribot, JL
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis,S Texas Ctr Biol Med, San Antonio, TX 78245 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Microbiol, San Antonio, TX 78245 USA
关键词
D O I
10.1128/AAC.45.9.2475-2479.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida albicans is implicated in many biomaterial-related infections. Typically, these infections are associated with biofilm formation. Cells in biofilms display phenotypic traits that are dramatically different from those of their free-floating planktonic counterparts and are notoriously resistant to antimicrobial agents. Consequently, biofilm-related infections are inherently difficult to treat and to fully eradicate with normal treatment regimens. Here, we report a rapid and highly reproducible microtiter-based colorimetric assay for the susceptibility testing of fungal biofilms, based on the measurement of metabolic activities of the sessile cells by using a formazan salt reduction assay. The assay was used for in vitro antifungal susceptibility testing of several C. albicans strains grown as biofilms against amphotericin B and fluconazole and the increased resistance of C albicans biofilms against these antifungal agents was demonstrated. Because of its simplicity, compatibility with a widely available 96-well microplate platform, high throughput, and automation potential, we believe this assay represents a promising tool for the standardization of in vitro antifungal susceptibility testing of fungal biofilms.
引用
收藏
页码:2475 / 2479
页数:5
相关论文
共 40 条
[1]   Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro [J].
Amorena, B ;
Gracia, E ;
Monzón, M ;
Leiva, J ;
Oteiza, C ;
Pérez, M ;
Alabart, JL ;
Hernández-Yago, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) :43-55
[2]  
Baillie GS, 1999, METHOD ENZYMOL, V310, P644
[3]   Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents [J].
Baillie, GS ;
Douglas, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1900-1905
[4]   Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B [J].
Baillie, GS ;
Douglas, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2146-2149
[5]  
BROWN R, 1989, PRACTICAL MED MICROB, P240
[6]   Oral colonization by Candida albicans [J].
Cannon, RD ;
Chaffin, WL .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1999, 10 (03) :359-383
[7]   The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms [J].
Ceri, H ;
Olson, ME ;
Stremick, C ;
Read, RR ;
Morck, D ;
Buret, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1771-1776
[8]   Cell wall and secreted proteins of Candida albicans:: Identification, function, and expression [J].
Chaffin, WL ;
López-Ribot, JL ;
Casanova, M ;
Gozalbo, D ;
Martinez, JP .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1998, 62 (01) :130-+
[9]   IMMUNOLOGICAL ASPECTS OF ORAL CANDIDIASIS [J].
CHALLACOMBE, SJ .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1994, 78 (02) :202-210
[10]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322